David A. Reis, Director at Genesis Healthcare, Inc. (GEN), sold 68 shares at $1.63 ($111) on 2018-08-14, disclosed to the SEC on 2018-08-27.
Scheduled sale ($111) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| GEN | SELL | 2018-11-15 | $53K | — | Filing → |
| GEN | SELL | 2018-11-13 | $73K | — | Filing → |
| GEN | SELL | 2018-11-09 | $92K | — | Filing → |